Hypertension in Low- and Middle-Income Countries
- PMID: 33793340
- PMCID: PMC8091106
- DOI: 10.1161/CIRCRESAHA.120.318729
Hypertension in Low- and Middle-Income Countries
Abstract
In recent decades low- and middle-income countries (LMICs) have been witnessing a significant shift toward raised blood pressure; yet in LMICs, only 1 in 3 are aware of their hypertension status, and ≈8% have their blood pressure controlled. This rising burden widens the inequality gap, contributes to massive economic hardships of patients and carers, and increases costs to the health system, facing challenges such as low physician-to-patient ratios and lack of access to medicines. Established risk factors include unhealthy diet (high salt and low fruit and vegetable intake), physical inactivity, tobacco and alcohol use, and obesity. Emerging risk factors include pollution (air, water, noise, and light), urbanization, and a loss of green space. Risk factors that require further in-depth research are low birth weight and social and commercial determinants of health. Global actions include the HEARTS technical package and the push for universal health care. Promising research efforts highlight that successful interventions are feasible in LMICs. These include creation of health-promoting environments by introducing salt-reduction policies and sugar and alcohol tax; implementing cost-effective screening and simplified treatment protocols to mitigate treatment inertia; pooled procurement of low-cost single-pill combination therapy to improve adherence; increasing access to telehealth and mHealth (mobile health); and training health care staff, including community health workers, to strengthen team-based care. As the blood pressure trajectory continues creeping upward in LMICs, contextual research on effective, safe, and cost-effective interventions is urgent. New emergent risk factors require novel solutions. Lowering blood pressure in LMICs requires urgent global political and scientific priority and action.
Keywords: developing countries; diet; epidemiology; lifestyle; risk factors.
Conflict of interest statement
Disclosures
None.
Figures




References
-
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115. doi: 10.1161/HYP.0000000000000065 - DOI - PubMed
-
- Institute for Health Metrics and Evaluation (IHME). Non-communicable Diseases - Level 1 Cause. IHME, University of Washington, 2019. Accessed December 16, 2020. http://www.healthdata.org/results/gbd_summaries/2019/non-communicable-di...
-
- Institute for Health Metrics and Evaluation (IHME). Cardiovascular Diseases - Level 2 Cause. IHME, University of Washington, 2019. Accessed December 16, 2020. http://www.healthdata.org/results/gbd_summaries/2019/cardiovascular-dise...
-
- Institute for Health Metrics and Evaluation (IHME). High Systolic Blood Pressure - Level 2 Risk. IHME, University of Washington, 2019. Accessed December 16, 2020. http://www.healthdata.org/results/gbd_summaries/2019/high-systolic-blood...
-
- Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383:1899–1911. doi: 10.1016/S0140-6736(14)60685-1 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous